Anemia is common in cancer patients and impacts on quality of life and prognosis. It is
typically multifactorial, often involving different pathophysiological mechanisms, making …

Introduction: In cancer patients, anemia is frequently observed, particularly as a
consequence to chemotherapy (chemotherapy-induced anemia, CIA). CIA is treated with …

Anemia in cancer patients is a relevant condition complicating the course of the neoplastic
disease. Overall, we distinguish the anemia which arises under chemotherapy as pure …

Cancer-related anemia (CRA) continues to be a critical concern despite advancements in
oncology treatments. The prevalence of anemia varies from 30% to 90%, impacting the …

Despite increasing use of targeted therapies to treat cancer, anemia remains a common
complication of cancer therapy. Physician concerns about the safety of intravenous (IV) iron …

Cancer and chemotherapy-induced anemia (CIA) is commonly encountered among patients
undergoing active chemotherapy with or without radiation therapy. Its pathogenesis is …

Background: Iron deficiency anemia (IDA) is a common cancer-related complication, and
intravenous (IV) iron administration has been reported to be effective in treating …

Anemia in cancer patients is quite common, with remarkable negative impacts on quality of
life and overall prognosis. The pathogenesis is complex and typically multifactorial, with iron …

9031 Background: The Mayo Clinic Cancer Research Consortium recently published results
from a phase III, randomized study (MC04CC) of darbepoetin alfa (DA) combined with …

Patients undergoing chemotherapy for cancer frequently experience anemia, which may
require red blood cell (RBC) transfusions. 1 The erythropoiesis-stimulating agents (ESAs) …